Highlights of Skin Disease Education Foundation’s 41st Annual Hawaii Dermatology SeminarTM

Highlights of Skin Disease Education Foundation’s 41st Annual Hawaii Dermatology Seminar

Highlights of Skin Disease Education Foundation’s 41st Annual Hawaii Dermatology SeminarTM

Jun
2017
Vol. 36. No. 3
Craig L. Leonardi, MD | Kenneth B. Gordon, MD | Lawrence F. Eichenfield, MD | Daniel Furst, MD | Neal Bhatia, MD | Katie Beleznay, MD
Skin Disease Education Foundation’s 41st Annual Hawaii Dermatology Seminar™. This educational supplement summarizes the highlights of clinical sessions presented during this CME/CE conference. A growing understanding of the biology of psoriasis has facilitated the development of increasingly efficacious medications. Skin clearance used to be regarded as an impractical goal for psoriasis therapy. Now, some clinical trials of newer medications report more than half of participants attaining Psoriasis Area and Severity Index (PASI) scores of 90. Two leading investigators review the latest findings about the treatment of this condition. Recent evidence demonstrates that psoriasis and psoriatic arthritis share multiple pathological underpinnings. A T helper type 17 (Th17) lymphocyte-based pathogenesis, genes, and microbiome changes have been identified in both conditions. Many therapeutics used in psoriasis care are efficacious in psoriatic arthritis. An expert in psoriatic arthritis updates readers about this condition. Cutaneous fungal infections, including onychomycosis, pose diagnostic and treatment challenges. New topical therapies and an investigational oral agent offer expanded options for management. The American Academy of Dermatology has issued new guidelines for the treatment of acne. Appropriate antibiotic use is a prominent theme. The US Food and Drug Administration has issued a communication about the risk of unintentional injection of soft tissue fillers into facial blood vessels—including blindness. The lead author of a recent review about this topic discusses how to prevent this serious outcome. The volume of new information about pathophysiology, diagnosis, therapy, and safety challenges our ability to keep current while enabling us to improve patient care. We hope that the highlights of this seminar offer you information that can be applied to your busy practices. Semin Cutan Med Surg 36(supp3):S51-S59
VIEW FULL ARTICLE PDF